Overall, PTHrP serves as both a mediator of physiological calcium homeostasis and a pathological driver of breast cancer progression and bone metastatic colonization, highlighting its potential as a therapeutic target in metastatic breast cancer. The gene discussed is PTHLH; the disease is breast carcinoma.